FR2362620A1 - Equipement de diagnostic - Google Patents

Equipement de diagnostic

Info

Publication number
FR2362620A1
FR2362620A1 FR7717220A FR7717220A FR2362620A1 FR 2362620 A1 FR2362620 A1 FR 2362620A1 FR 7717220 A FR7717220 A FR 7717220A FR 7717220 A FR7717220 A FR 7717220A FR 2362620 A1 FR2362620 A1 FR 2362620A1
Authority
FR
France
Prior art keywords
equipment
diagnostic equipment
phytate
calcium
calcium chloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7717220A
Other languages
English (en)
French (fr)
Other versions
FR2362620B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of FR2362620A1 publication Critical patent/FR2362620A1/fr
Application granted granted Critical
Publication of FR2362620B1 publication Critical patent/FR2362620B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/081—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the protein being an albumin, e.g. human serum albumin [HSA], bovine serum albumin [BSA], ovalbumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1255—Granulates, agglomerates, microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7717220A 1976-06-07 1977-06-06 Equipement de diagnostic Granted FR2362620A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA254,190A CA1053149A (en) 1976-06-07 1976-06-07 Diagnostic kit

Publications (2)

Publication Number Publication Date
FR2362620A1 true FR2362620A1 (fr) 1978-03-24
FR2362620B1 FR2362620B1 (enExample) 1980-04-18

Family

ID=4106144

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7717220A Granted FR2362620A1 (fr) 1976-06-07 1977-06-06 Equipement de diagnostic

Country Status (9)

Country Link
JP (1) JPS52151733A (enExample)
BE (1) BE855380A (enExample)
CA (1) CA1053149A (enExample)
CH (1) CH629964A5 (enExample)
DE (1) DE2725666A1 (enExample)
DK (1) DK218877A (enExample)
FR (1) FR2362620A1 (enExample)
GB (1) GB1545024A (enExample)
NL (1) NL7705402A (enExample)

Also Published As

Publication number Publication date
JPS52151733A (en) 1977-12-16
FR2362620B1 (enExample) 1980-04-18
DE2725666A1 (de) 1977-12-15
BE855380A (fr) 1977-12-05
JPS624372B2 (enExample) 1987-01-30
CA1053149A (en) 1979-04-24
CH629964A5 (en) 1982-05-28
NL7705402A (nl) 1977-12-09
GB1545024A (en) 1979-05-02
DK218877A (da) 1977-12-08

Similar Documents

Publication Publication Date Title
FR2457891A1 (enExample)
KR870006039A (ko) 신규 티아졸 화합물, 그 제조방법 및 이 화합물을 함유하는 약학적 조성물
ATE38672T1 (de) 7-oxabicycloheptan aminosubstituierte prostaglandinaehnliche verbindungen.
RU94027577A (ru) Производные 1-бензолсульфонил-1,3-дигидро-2н-бензимидазол-2-она, способ их получения, содержащая их фармацевтическая композиция
HU9603387D0 (en) Monoclonal antibody active against cd44v6
GB1457082A (en) Check or non-return valves process for the preparation of 1-substi
BE1003188A4 (fr) Composition pharmaceutique destinee a etre administree par voie orale et contenant de la n-acetyl-cysteine, et son application.
FR2397838A1 (fr) Preparation de gamma globuline naturelle lyophilisee pour administration intraveineuse
GB1417003A (en) Stabilisation of fibrinogen
IL102460A0 (en) Method for enhancing the immunotherapeutic activity of lymphocytes and agents and kits containing lymphocytes of enhanced activity
IE43217L (en) Solubilisation of casein.
KR840006492A (ko) 플라티늄-디아민 착화물의 제조 방법
Elliott et al. Antigen recognition by T cells activated in the mixed lymphocyte reaction: specific binding of allogeneic cell material after removal of surface‐bound antigen by trypsin
FR2362620A1 (fr) Equipement de diagnostic
BG43867A3 (en) Method for preparing of 6- alpha- methylcorticoids
EP0150710A3 (en) 7-oxabicycloheptane prostaglandin analogs
IL73721A (en) (4-and/or 6-substituted o-acyl)glycosylamides,ureas and carbamates,their preparation and pharmaceutical compositions containing them
GB1469616A (en) Optical resolution of phenyl-glycine amide
FR2361414A1 (fr) Processus de determination d'immunite en utilisant de nouveaux composes immunochimiques
CA2134560A1 (en) Anti-obesity drugs
GB1356873A (en) Fungicidal compositions and their use
FR2361826A1 (fr) Produit alimentaire dietetique et son procede de preparation
GB1366664A (en) 3 - /3 - cyanopropyl/ - cyclopenta /f/ /1/ benzopyrans and the preparation thereof
GB1292253A (en) Herbicidal composition and method
EP0116848A3 (en) Composition for hair-treatment

Legal Events

Date Code Title Description
ST Notification of lapse